IMPACT OF NEXTSENSE INSTITUTE RESEARCH IN THE FIELD OF SENSORY DISABILITIES
With
Professor Greg Leigh AO,
Director, NextSense Institute, Australia &
Conjoint Professor,
Macquarie School of Education
Macquarie University, Sydney
RESEARCH IMPACT
Filmed in Sydney, Australia | June 2025
NextSense, formerly known as the Royal Institute for Deaf & Blind Children, is a not-for-profit established in 1860 that provides dedicated, innovative, and customised services aimed at breaking down barriers for children, adults and families of people with hearing or vision loss.
NextSense has a 165 year history of providing services and education for individuals with sensory impairments. With the support of donations, NextSense provides vital support for children and adults, more cochlear implants than any other service in Australia, and is a world leader for research, technology and professional education in the fields of visions and hearing loss.
NextSense clinicians are actively involved in a number of leading research projects—both independently and in collaboration with local and international organisations.
The NextSense Institute, part of NextSense is Australia’s leading centre for research and professional education in the field of sensory disabilities.
The Institute offers a range of educational programs, including postgraduate degrees, professional development courses, and customised training for educators, therapists, health professionals, and carers. One of its flagship programs is the Master of Disability Studies, delivered in affiliation with Macquarie University, which prepares professionals to work with individuals who are deaf, hard of hearing, blind, or have low vision.
Professor Greg Leigh AO, Director NextSense Institute, talks about 3 areas of research that have had significant impact in it’s delivery of programs and services to Australians and countries across the world.
Through this research, NextSense Institute aims to break down barriers and redefine what is possible for individuals with sensory disabilities, fostering inclusion and enhancing quality of life.
Source: Written by AUDIENCED using source information from the NextSense website
-
Engineering bacteria to detect colorectal cancer cells
An international team of researchers from Adelaide and the United States has engineered bacteria capable of detecting mutated DNA released from colorectal cancer cells, opening the door to faster disease detection.
-
Identification & characterisation of molecular drivers of therapeutic resistance
Professor Pieter Eichhorn is an internationally experienced cancer biologist and research leader whose career has been defined by high-impact contributions at the interface of functional genomics, translational oncology, and research infrastructure strategy.
He completed his PhD at the University of Newcastle upon Tyne, contributing to the cloning of the gene associated with Cornelia de Lange Syndrome, before undertaking postdoctoral training at the Netherlands Cancer Institute in the laboratory of René Bernards. There, he performed pioneering functional genetic screens that identified key regulators of oncogenesis and therapy resistance, including critical roles for the PI3K signalling pathway in resistance to targeted breast cancer therapies.
-
Systems genetics to determine risk of developing diabetes complications
Professor Morahan invented the term “Systems Genetics” for the science field that examines how genetic variants can affect whole networks of genes and whole systems; there are now several laboratories and institutes of systems genetics around the world. He also developed the next-generation genetic resource, The Gene Mine, the most powerful of its type in the world, used globally in rapid mapping and identification of genes. Collaborators nationally and internationally have tested The Gene Mine for traits and diseases in which they specialise.
